We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$356M
2
PYPL icon
PayPal
PYPL
+$290M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$261M
4
NVDA icon
NVIDIA
NVDA
+$248M
5
AABA
Altaba Inc
AABA
+$245M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 10.66%
3 Consumer Discretionary 10.29%
4 Communication Services 8.78%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVH
3326
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$105K ﹤0.01%
+13,556
New +$101K
AVID
3327
DELISTED
Avid Technology Inc
AVID
$104K ﹤0.01%
22,945
+9,148
+66% +$43.4K
IMDZ
3328
DELISTED
Immune Design Corp.
IMDZ
$104K ﹤0.01%
10,023
-10,099
-50% -$99.4K
SGYP
3329
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$103K ﹤0.01%
35,349
-11,310
-24% -$38.6K
GAU
3330
Galiano Gold
GAU
$612M
$102K ﹤0.01%
107,809
-540,759
-83% -$634K
ATHX
3331
DELISTED
Athersys, Inc. Common Stock
ATHX
$102K ﹤0.01%
+1,976
New +$89K
AMFW
3332
DELISTED
AMEC Foster Wheeler plc
AMFW
$102K ﹤0.01%
15,084
-243
-2% -$1.42K
CMRE icon
3333
Costamare
CMRE
$1.89B
$101K ﹤0.01%
+16,372
New +$106K
ERIC icon
3334
Ericsson
ERIC
$33.5B
$99K ﹤0.01%
+17,269
New +$107K
CRK icon
3335
Comstock Resources
CRK
$4.18B
$95K ﹤0.01%
15,557
+5,490
+55% +$35.7K
IIP
3336
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$95K ﹤0.01%
21,754
-93,907
-81% -$410K
WPRT
3337
Westport Fuel Systems
WPRT
$34.8M
$93K ﹤0.01%
2,845
-7,700
-73% -$173K
ONIT
3338
Onity Group
ONIT
$301M
$93K ﹤0.01%
+1,798
New +$78.4K
ACHN
3339
DELISTED
Achillion Pharmaceuticals
ACHN
$91K ﹤0.01%
20,327
-4,914
-19% -$21.8K
CRBP icon
3340
Corbus Pharmaceuticals
CRBP
$201M
$90K ﹤0.01%
+421
New +$82.4K
ANDAR
3341
DELISTED
Andina Acquisition Corp. II Right
ANDAR
$88K ﹤0.01%
148,992
-5,208
-3% -$2.51K
KGC icon
3342
Kinross Gold
KGC
$38.9B
$84K ﹤0.01%
19,882
-12,587
-39% -$53.8K
ADXS
3343
CALL
DELISTED
Advaxis Inc
ADXS
$84K ﹤0.01%
1,333
– –
ELDN icon
3344
Eledon Pharmaceuticals
ELDN
$280M
$82K ﹤0.01%
871
– –
MNOV icon
3345
MediciNova
MNOV
$68.4M
$80K ﹤0.01%
+12,542
New +$66.7K
OCSL icon
3346
Oaktree Specialty Lending
OCSL
$1.14B
$80K ﹤0.01%
4,890
-37,529
-88% -$599K
ANW
3347
DELISTED
Aegean Marine Petroleum Network
ANW
$80K ﹤0.01%
16,195
-27,893
-63% -$138K
ALTO icon
3348
Alto Ingredients
ALTO
$340M
$79K ﹤0.01%
+14,313
New +$78K
AREX
3349
DELISTED
Approach Resources Inc.
AREX
$77K ﹤0.01%
30,415
-47,881
-61% -$132K
FLNA
3350
Filana Therapeutics
FLNA
$46.4M
$76K ﹤0.01%
18,557
– –
132 133
134
135 136

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q3 2017 Portfolio in Review

As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
  • David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • David Shaw opened 469 new positions and closed 370 in Q3 2017.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.